[Isoniazid As a Mutagen (author's Transl)]

Overview

Journal Pneumonologie

Specialty Pulmonary Medicine

Date 1973 Aug 24

PMID 4592957

Citations 1

Authors

E KEHLER

G ROHRBORN

P Propping

W Buselmaier

Affiliations

Soon will be listed here.

Citing Articles

Actual status of mutageneity testing with the host-mediated assay.

Mohn G Arch Toxicol. 1977; 38(1-2):109-33.

PMID: 143925 DOI: 10.1007/BF00293669.

References

Toth B, SHUBIK P . Mammary tumor inhibition and lung adenoma induction by isonicotinic acid hydrazide. Science. 1966; 152(3727):1376-7. DOI: 10.1126/science.152.3727.1376. View

FEREBEE S . Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970; 26:28-106. View

VIALLIER J, Casanova F . [Does isoniazid possess cancerigenic properties? Trial on animals]. C R Seances Soc Biol Fil. 1960; 154:985-7. View

Toth B, Rustja M . The effect of isonicotinic acid hydrazide on the development of tumors. Int J Cancer. 1967; 2(5):413-20. DOI: 10.1002/ijc.2910020502. View

Juhasz J, BALO J, Szende B . [New experimental data on the tumor-inducing effect of isonicotinic acid hydrazide (INH)]. Z Krebsforsch. 1963; 65:434-8. View

Epstein S, Shafner H . Chemical mutagens in the human environment. Nature. 1968; 219(5152):385-7. DOI: 10.1038/219385a0. View

Mori K, YASUNO A, Matsumoto K . Induction of pulmonary tumors in mice with isonicotinic acid hydrazid. Gan. 1960; 51:83-90. View

Rosenkranz H, CARR H . Hydrazine antidepressants and isoniazid: potential carcinogens. Lancet. 1971; 1(7713):1354-5. DOI: 10.1016/s0140-6736(71)91913-1. View

Freese E, Sklarow S, Freese E . DNA damage caused by antidepressant hydrazines and related drugs. Mutat Res. 1968; 5(3):343-8. DOI: 10.1016/0027-5107(68)90004-3. View

10.

ROHRBORN G, Propping P, Buselmaier W . Mutagenic activity of isoniazid and hydrazine in mammalian test systems. Mutat Res. 1972; 16(2):189-94. DOI: 10.1016/0027-5107(72)90179-0. View

11.

Lenghel V . Isoniazid-induced chromosome aberrations. Lancet. 1971; 2(7715):93. DOI: 10.1016/s0140-6736(71)92065-4. View

12.

HAMMOND E, SELIKOFF I, ROBITZEK E . Isoniazid therapy in relation to later occurrence of cancer in adults and in infants. Br Med J. 1967; 2(5555):792-5. PMC: 1843149. DOI: 10.1136/bmj.2.5555.792. View

13.

Biancifiori C, Ribacchi R . Pulmonary tumours in mice induced by oral isoniazid and its metabolites. Nature. 1962; 194:488-9. DOI: 10.1038/194488a0. View

14.

Gabridge M, Legator M . A host-mediated microbial assay for the detection of mutagenic compounds. Proc Soc Exp Biol Med. 1969; 130(3):831-4. DOI: 10.3181/00379727-130-33666. View

15.

Peacock A, Peacock P . The results of prolonged administration of isoniazid to mice, rats and hamsters. Br J Cancer. 1966; 20(2):307-25. PMC: 2008955. DOI: 10.1038/bjc.1966.39. View

16.

Biancifiori C, Bucciarelli E, CLAYSON D, SANTILLI F . INDUCTION OF HEPATOMAS IN CBA-CB-SE MICE BY HYDRAZINE SULPHATE AND THE LACK OF EFFECT OF CROTON OIL ON TUMOUR INDUCTION IN BALB-C-CB-SE MICE. Br J Cancer. 1964; 13:543-50. PMC: 2071093. DOI: 10.1038/bjc.1964.62. View

17.

Propping P, ROHRBORN G, Buselmaier W . Comparative investigations on the chemical induction of point mutations and dominant lethal mutations in mice. Mol Gen Genet. 1972; 117(3):197-209. DOI: 10.1007/BF00271647. View

18.

Schwan S . [Isonicotinic acid hydrazide (INH) as a "carcinogenic" wgent in mice. II]. Patol Pol. 1962; 13:185-94. View